We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
FORSTEO(R) Receives Approval From The European Commission For The Treatment Of Glucocorticoid Induced Osteoporosis
Bones / Orthopaedics Eli Lilly and Company (NYSE: LLY) announced that the European Commission has approved a new indication for FORSTEO(R) (teriparatide [rDNA origin] injection) for the treatment of osteoporosis associated with sustained, systemic glucocorticoid therapy in women and men at increased risk for fracture.This approval follows the initial positive opinion issued in February by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA).
